Open Internet by MindsNet

Biohacking Industry Efficacy Problem

The biohacking industry, valued at $450 billion, faces a significant challenge regarding the efficacy of its products and services. Despite the high spending by consumers, such as Bryan Johnson's $2 million annual expenditure, the scientific basis and effectiveness of most biohacking solutions are questionable. A recent study and a New York Times report highlight that much of what the industry offers does not work as claimed.

Science, Medicine, Pathology